Seeking Alpha

  Threshold Pharmaceuticals, Inc. (THLD) - NASDAQ

  • The Scientist | Send Message 24 Aug 2012

    THLD with continued high short interest. Of all the stocks to short, this is one of the worst. Solid data. Potential to go up 10x quickly
    Reply (3)
  • View all 3 replies
    • The Scientist | Send Message 27 Aug 2012
      : Th-302 could be the breakthru drug that oncologists have been looking for. By targeting hypoxic niche, kills CSCs that promotes recurrence
    • The Scientist | Send Message 31 Aug 2012
      : Hypoxic CSCs r the 'untouchables' in oncology. Must b killed, but cannot get to them.
      THLD vs. ETF Alternatives
      Company Description
      Threshold Pharmaceuticals, Inc. is a biotechnology company. It focuses on the discovery and development of drugs targeting the microenvironment of solid tumors as novel treatments for patients living with cancer.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States